CORCEPT THERAPEUTICS

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily ... oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

#SimilarOrganizations #People #Financial #Event #Website #More

CORCEPT THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Medical Pharmaceutical

Founded:

1998-01-01

Address:

Menlo Park, California, United States

Country:

United States

Website Url:

http://www.corcept.com

Total Employee:

51+

Status:

Active

Contact:

16503273218

Email Addresses:

[email protected]

Total Funding:

80.09 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

Current Advisors List

patrick-enright_image

Patrick Enright Member of the Board of Directors @ Corcept Therapeutics
Board_member
2008-01-01

david-mahoney_image

David Mahoney Member of the Board of Directors @ Corcept Therapeutics
Board_member
2005-01-01

daniel-m-bradbury_image

Daniel M. Bradbury Board of Directors @ Corcept Therapeutics
Board_member

gregg-h-alton_image

Gregg H. Alton Board Member @ Corcept Therapeutics
Board_member
2020-03-01

jim-wilson_image

Jim Wilson Chairman of the Board @ Corcept Therapeutics
Board_member

joseph-turner_image

Joseph Turner Member of the Board of Directors @ Corcept Therapeutics
Board_member

Current Employees Featured

not_available_image

Joseph K. Belanoff
Joseph K. Belanoff Chief Executive Officer @ Corcept Therapeutics
Chief Executive Officer

not_available_image

Rob Adamoski
Rob Adamoski Vice President Marketing and Training @ Corcept Therapeutics
Vice President Marketing and Training
2016-05-01

yuan-xu_image

Yuan Xu
Yuan Xu Senior Manager, Statistical Programming @ Corcept Therapeutics
Senior Manager, Statistical Programming
2020-09-01

Founder

david-singer_image

David Singer

Stock Details

Company's stock symbol is NASDAQ:CORT

Investors List

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Post-IPO Equity - Corcept Therapeutics

alta-partners_image

Alta Partners

Alta Partners investment in Post-IPO Equity - Corcept Therapeutics

longitude-capital_image

Longitude Capital

Longitude Capital investment in Post-IPO Equity - Corcept Therapeutics

alta-partners_image

Alta Partners

Alta Partners investment in Post-IPO Equity - Corcept Therapeutics

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Post-IPO Equity - Corcept Therapeutics

paperboy-ventures_image

Paperboy Ventures

Paperboy Ventures investment in Post-IPO Equity - Corcept Therapeutics

Newest Events participated

Participated in 12th Annual Cardiometabolic Health Congress on 2017-10-04 as exhibitor

Official Site Inspections

http://www.corcept.com Semrush global rank: 1.13 M Semrush visits lastest month: 28.49 K

Host Informations
Whois Informations

Loading ...

More informations about "Corcept Therapeutics" on Search Engine